San Francisco, CA — International Business Times reports that on Monday, opening night of the pharmaceutical industry's largest gathering , executives at a “Future of Pharma” forum will mull a simple question that both befuddles and enthralls them: What is innovation, and how can companies spur it?
Innovation is the industry's most coveted and elusive concept. The rewards are clearly visible: breakthrough treatments that help patients and generate billions in sales. But few experts agree on metrics or best practices for achieving it. Direct comparisons of companies are often imperfect. Like many buzzwords, its very definition is diffuse.
Innovation is the industry's most coveted and elusive concept. The rewards are clearly visible: breakthrough treatments that help patients and generate billions in sales. But few experts agree on metrics or best practices for achieving it. Direct comparisons of companies are often imperfect. Like many buzzwords, its very definition is diffuse.
